Stock Analysis
American Healthcare REIT, Inc.AHR
P/E 95.88×· 3Y range 81.55–325.58×· 50th percentile of history
Sector: Real Estate · Industry: Real Estate Investment Trusts
AnalystsStrong Buy19 analystsP/E 95.9× sits at the 50th percentile of its 2.688455395847593-year history.
Cash covers 10% of debt · Q2 2026.
PMP Verdict
Mixed fundamentals, fairly valued
Strengths
- Quality67
Risks
- Profitability35
- Financial Health39
Mixed picture — no clear quality or value edge.
Bull Case
- ✓Piotroski F-Score 7/9 — high earnings quality
- ✓Revenue CAGR 13.5% — durable top-line growth
What's happening with AHR
Profile
moat, profitability, financial health, growth and valuation lag behind.
How is each axis scored?
- Valuation47/100 · Weak
- P/E vs own history (50th pct)12/25
- FCF yield (n/a)10/25
- P/S (5.0x)20/25
- EV/EBIT (39.2x)5/25
- Growth45/100 · Weak
- Revenue CAGR (13.5%)20/25
- Net income CAGR (n/a)0/25
- EPS CAGR 5Y (n/a)0/25
- Fwd implied growth (38.1%)25/25
- Profitability35/100 · Weak
- ROIC (5.1%)5/25
- ROE (3.2%)5/25
- Net margin (5.2%)13/25
- Operating margin (14.2%)12/25
- Financial Health39/100 · Weak
- Altman Z (0.01)3/25
- Current ratio (0.85)6/25
- Interest coverage (7.7x)18/25
- Net cash / debt (D/A 25%)12/25
- Quality67/100 · Moderate
- Piotroski F (7/9)22/25
- Beneish M (-2.56)25/25
- FCF conversion (n/a)0/25
- Margin stability (σ 6.3%)20/25
- Moat0/100 · Weak
- ROIC >12% years (0/4 yrs)0/25
- Median gross margin (11.1%)0/25
- FCF-positive years (n/a)0/25
- Worst-year net margin (worst -5.8%)0/25
Risk Flags
- ⚠Altman Z 0.0 — distress-zone balance sheet
- ⚠4 loss-making years in recent history
About American Healthcare REIT, Inc.
American Healthcare REIT Inc is a healthcare-focused real estate investment trust. Show more
It owns a diversified portfolio of clinical healthcare real estate properties, focusing on medical office buildings, skilled nursing facilities, senior housing, hospitals, and other healthcare-related facilities. It has four reportable business segments: integrated senior health campuses, outpatient medical, triple-net leased properties and SHOP. It generates majority of its revenue through Integrated Senior Health Campuses segment.
Headquarters: IRVINE, CA · Employees: 121 · Website ↗
Price History
Weekly Candlestick Chart — up to 5Y
Key Metrics
Financial snapshot · Tap any metric for its definition and grade
TTM Snapshot
trailing twelve months · YoYValuation
47D+P/E (TTM)95.9xD
Grade D: ExpensivePrice / TTM EPS (own statements) — vs own 3Y history: 81.5x–325.6x · 50th pct
P/FCF148.9xD
Grade D: ExpensivePrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative
FCF Yield0.7%C
Grade C: LowInverse of Finnhub P/FCF (own TTM FCF unavailable)
P/S (TTM)4.96xB
Grade B: FairPrice / TTM Revenue (own statements) — vs own 3Y history: 0.5x–5.0x · highest in history
EV/EBIT39.2xD
Grade D: ExpensiveEnterprise value / TTM EBIT (D&A not in our data) — capital-structure neutral — vs own 3Y history: 38.7x–260.0x · 4th pct
EV/Sales5.2xC
Grade C: ExpensiveEnterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple
Forward P/E69.4xD
Grade D: ExpensivePrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth
P/B Ratio3.10xC
Grade C: ExpensivePrice to Book Value. Neg. equity = heavy buybacks
PEG Ratio3.73D
Grade D: ExpensiveFinnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)
Dividend Yield1.53%A
Grade A: PaysTTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress
Payout Ratio147.5%D
Grade D: UnsustainableDividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable
Profitability
35DROIC5.1%D
Grade D: LowNOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat
ROE3.2%D
Grade D: WeakReturn on Equity. Neg. equity = heavy buybacks
ROA2.3%D
Grade D: WeakReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit
Net Margin5.2%C
Grade C: AverageNet Income / Revenue
Operating Margin14.2%C
Grade C: AverageTTM EBIT / TTM Revenue
Gross Margin15.6%D
Grade D: LowGross Profit / Revenue
FCF Margin—
FCF / Revenue
True FCF Margin—
TTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost
Growth
45D+Revenue CAGR13.5%C
Grade C: OkCompound annual revenue growth (up to 5Y depending on data availability)
Net Income CAGR—
Compound annual net income growth (up to 5Y depending on data availability)
EPS CAGR (5Y)—
Compound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0
Implied EPS Growth38.1%A
Grade A: HighAnalyst forward EPS (normalized basis) vs our GAAP TTM EPS — different bases, so extreme values usually mark cyclically depressed TTM earnings, not real growth
Dilution (5Y)—
Share count change over 5Y
SBC / Net Income16.1%C
Grade C: MedStock-based comp/Net income. >30% = dilution risk
SBC / Revenue0.8%A
Grade A: LowTTM stock-based comp / TTM Revenue
Financial Health
39DAltman Z-Score0.01D
Grade D: DistressBankruptcy risk. >3 Safe, <1.8 Distress
Current Ratio0.85xD
Grade D: LowCurrent Assets/Liabilities
Quick Ratio0.85xC
Grade C: Ok(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory
Interest Coverage7.7xC
Grade C: OkEBIT/Interest. >10 Strong
Debt Repayment—
Years to repay net debt via FCF
Net Debt/EBIT4.2xD
Grade D: HighLeverage. <2x Low, >4x High
Debt/Equity0.42xA
Grade A: LowDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.
Cash / Debt0.10xD
Grade D: ThinCash covers how much of total debt. >1 = could repay all debt from cash
Quality
67BPiotroski F-Score7/9A
Grade A: StrongFinancial strength 0–9. >7 Strong
Beneish M-Score-2.56A
Grade A: SafeEarnings manipulation risk. < -2.22 Safe
FCF Conversion—
FCF / Net Income
Margin Stability6.3%A
Grade A: StableEBIT margin std deviation. Lower = stable
Capex / Revenue—
TTM CapEx / TTM Revenue — high % = capital-hungry business
Asset Turnover0.47xD
Grade D: LowRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales
Insider Transactions
SEC Form 4 · 8 recordsP/S codes are the directional signal; grants, option exercises and tax withholding carry none. Form 4 doesn't flag 10b5-1 plans — scheduled sales may appear within open-market sells.
| Trade date | Insider | Transaction | Shares | Filed |
|---|---|---|---|---|
Foster Mark E. Filed | Foster Mark E. | SellOpen market sale | -1500 | |
Foster Mark E. Filed | Foster Mark E. | SellOpen market sale | -2000 | |
Prosky Danny Filed | Prosky Danny | Grant / award | +2.6K | |
Willhite Gabriel M Filed | Willhite Gabriel M | Grant / award | +6.0K | |
Prosky Danny Filed | Prosky Danny | Option exercise | -20912 |
Show 3 more filingsShow fewer filings
| Trade date | Insider | Transaction | Shares | Filed |
|---|---|---|---|---|
Prosky Danny Filed | Prosky Danny | Option exercise | -30886 | |
Prosky Danny Filed | Prosky Danny | Tax withholding | -11283 | |
Prosky Danny Filed | Prosky Danny | Option exercise | +20.9K |
Option exercise (M) rows report a derivative leg, not an open-market sale — a paired negative entry is the option position being consumed.
More metrics — Moat, Per Share, Balance Sheet, MarketHide additional metrics
Moat
0EROIC >12% Years0/4 yrsD
Grade D: WeakShare of completed fiscal years with ROIC > 12% — measures multi-year capital-return durability
Gross Margin (Med.)11.1%D
Grade D: WeakMedian annual gross margin across available fiscal years — pricing-power durability
FCF-Positive Years—
Share of completed fiscal years with positive free cash flow
Net Margin Floor-5.8%D
Grade D: WeakWeakest annual net margin across completed fiscal years — recession/downcycle resilience
Per Share
EPS (TTM)$0.56
Own TTM net income / shares — same earnings basis as P/E
Cash / Share$0.81
Cash & short-term investments per share (Finnhub)
Book Value / Share$18.98
Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks
Balance Sheet
Total Debt$1.57B
Total debt obligations (short + long term)
Cash & Equiv.$156.90M
Cash and short-term investments
Net Debt$1.41B
Total Debt minus Cash. Negative = Net Cash position
Total Equity$3.74B
Shareholders' equity (book value)
Asset / Liability—
Total Assets / Total Liabilities
Market
Market Cap$11.60B
Current Market Capitalization
Beta0.83B
Grade B: MarketPrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings
How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.
Financials as of Jun 2026 · Ratio snapshot Oct 17, 2026
Key Insights: American Healthcare REIT, Inc. (AHR)
American Healthcare REIT, Inc. meets 7 of 9 Piotroski F-Score criteria, placing its fundamental strength in the top tier of US-listed stocks. Altman Z-Score of 0.01 is below the 1.81 distress threshold — an elevated financial-risk flag.
- Beneish M-Score of -2.56 suggests a low likelihood of earnings manipulation.
- American Healthcare REIT, Inc. posted a net loss in 4 of 5 available completed fiscal years (2021–2025).
See how AHR ranks on the Capex Tracker — top 50 capital spenders compared.
Recent Market Moves
See all AHR moves →| Date | Session | Price | Move | Z-Score |
|---|---|---|---|---|
| Oct 12 | Regular | 52.44 | +3.23% | 3.34 |
| Oct 12 | After-hours | 52.52 | +3.39% | 3.49 |
| Oct 8 | Regular | 50.58 | +2.44% | 3.51 |
| Oct 8 | After-hours | 50.44 | +2.17% | 3.19 |
| Oct 7 | Regular | 49.54 | -1.88% | -2.12 |
Frequently Asked Questions about AHR
What is the current American Healthcare REIT, Inc. (AHR) stock price?
AHR is trading at $53.23 at the last market close, up 0.42% on the session. PreMarketPrice tracks AHR pre-market, intraday and after-hours prices.
Is AHR stock a buy right now?
PreMarketPrice's quantitative model rates American Healthcare REIT, Inc.'s financial health at 39/100. This is a data-driven snapshot of fundamentals, not investment advice.
Is AHR stock overvalued?
American Healthcare REIT, Inc. trades at a trailing P/E of 95.9 and our valuation score rates it 47/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.
When does American Healthcare REIT, Inc. report earnings?
No confirmed earnings date is currently scheduled for AHR. The Earnings section lists recent reports and updates as dates are announced.
What sector does American Healthcare REIT, Inc. operate in?
American Healthcare REIT, Inc. operates in the Real Estate sector, within the Real Estate Investment Trusts industry. The Related Stocks section lists sector peers for comparison.
What does American Healthcare REIT, Inc. do?
American Healthcare REIT Inc is a healthcare-focused real estate investment trust.
About American Healthcare REIT, Inc. (AHR) Stock
American Healthcare REIT, Inc. (AHR) is a US-listed stock operating in the Real Estate sector, specifically the Real Estate Investment Trusts industry. As of the latest update, American Healthcare REIT, Inc. is trading at $53.23, up 0.42% on the day with a market capitalization of $11.6 billion. The financial health score for AHR is 39/100, which indicates weak financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for AHR stock.
AHR Stock Analysis & Key Metrics
On PreMarketPrice, you can track American Healthcare REIT, Inc. (AHR) across multiple dimensions:
- Pre-market price & movement: Real-time AHR stock price with percentage change, updated continuously during pre-market and regular trading hours.
- Valuation & P/E history: Historical P/E, P/S, and P/B ratios for AHR with trend analysis and normalized valuation multiples.
- Financial statements: Revenue, net income, assets, liabilities, and equity for American Healthcare REIT, Inc. across multiple reporting periods.
- Financial health score: A composite score of 39/100 based on Altman Z-Score, Piotroski F-Score, profitability, and leverage metrics for AHR.
- Sector peers: Compare AHR against 5 other real estate stocks on key financial metrics.
Is AHR a Good Stock to Buy?
This page provides data-driven analysis to help you evaluate American Healthcare REIT, Inc. (AHR) as an investment. The financial health score of 39/100 suggests weak financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.
Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.American Healthcare REIT, Inc. (AHR) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.